Showing 2001-2010 of 2038 results for "".
- Alcon Launches Alcon Retina Fellows Institute to Support Future Leaders of Ophthalmologyhttps://modernod.com/news/alcon-launches-alcon-retina-fellows-institute-to-support-future-leaders-of-ophthalmology/2479630/Alcon announced it is expanding its support of eye care professionals through the launch of a one-of-a-kind training opportunity, the Alcon Retina Fellows Institute. The unique educational offering supports retina fellows during a weekend-long training at the Alcon Experience Center in Fort Worth
- FDA Approves Genentech’s ACTPen, the Actemra Autoinjector, for Giant Cell Arteritis, Other Indicationshttps://modernod.com/news/fda-approves-genentechs-actpen-the-actemra-autoinjector-for-giant-cell-arteritis-other-indications/2479647/Genentech announced that the FDA has approved ACTPen 162 mg/0.9 mL, a single-dose prefilled autoinjector for Actemra (tocilizumab), as an additional formulation for adult patients with moderate to severe active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-m
- Georgia Eye Associates Affiliates with EyeSouth Partnershttps://modernod.com/news/georgia-eye-associates-affiliates-with-eyesouth-partners/2479657/EyeSouth Partners has announced that it has completed a strategic partnership with Georgia Eye Associates, expanding its presence into the Lawrenceville and northeast Atlanta regions. EyeSouth is an eye care-focused physician services organization formed by Shore Capital Partners, a leading lower
- U.S. Appeals Court Rules Against Allergan Over Validity of Restasis Patentshttps://modernod.com/news/u-s-appeals-court-rules-against-allergan-over-validity-of-restasis-patents/2479660/Allergan’s patents on its blockbuster eye drug Restasis are invalid, a U.S. appeals court ruled, according to a Bloomberg report. Without issuing a formal opinion, the U.
- American Academy of Optometry Announces Barbara Caffery, OD, PhD, FAAO, as Presidenthttps://modernod.com/news/american-academy-of-optometry-names-barbara-caffery-od-phd-faao-as-president/2479665/The American Academy of Optometry has named Barbara Caffery, OD, PhD, FAAO, the incoming President of the American Academy of Optometry. Dr. Caffery was formally inducted during the Academy’s annual meeting in San Antonio, Texas on November 10, 2018. She is the first Canadian woman to serve as pr
- Bausch’s Papa Says ‘Transformation on Track’ as Debt Paydown Continueshttps://modernod.com/news/bauschs-papa-says-transformation-on-track-as-debt-paydown-continues/2479690/The turnaround at Quebec-based Bausch Health Cos. appeared to take another step forward Tuesday, after the company reported positive organic growth for the third quarter, sending shares up more than five percent in Toronto, according to a Financial Post
- Clearside Biomedical’s Combination Therapy in RVO Does Not Meet Primary Endpoint in Phase 3 Trialhttps://modernod.com/news/clearside-biomedicals-combination-therapy-in-rvo-does-not-meet-its-primary-endpoint-in-phase-3-trial/2479701/Clearside Biomedical announced that the primary endpoint was not achieved in its phase 3 clinical trial (SAPPHIRE) investigating the superiority of XIPERE (formerly suprachoroidal CLS-TA) used together with the intravitreal anti-VEGF agent Eylea (aflibercept), compared to intravit
- ProQR In-licenses Worldwide Rights to Ophthalmology Drug Candidate from Ionis Pharmaceuticalshttps://modernod.com/news/proqr-in-licenses-worldwide-rights-to-ophthalmology-drug-candidate-from-ionis-pharmaceuticals/2479723/ProQR Therapeutics announced the signing of an agreement with Ionis Pharmaceuticals to license QR-1123 (formerly IONIS-RHO-2.5Rx), an RNA medicine for autosomal dominant retinitis pigmentosa (adRP) caused by the P23H mutation in the rhodopsin (RHO) gene. “Building on th
- CooperVision’s Best Practices Reveal Inaugural EYEdea Lab Findings at Vision Expo Westhttps://modernod.com/news/coopervisions-best-practices-reveal-inaugural-eyedea-lab-findings-at-vision-expo-west/2479796/A panel at the Global Contact Lens Forum at Vision Expo West presented findings from the inaugural CooperVision Best Practices EYEdea Lab. Designed to help eye care professionals (ECPs) improve patient experiences and remain competitive amidst disruptive consumer healthcare purchasing trends, the
- ASCRS Releases Preliminary CyPass Withdrawal Consensus Statementhttps://modernod.com/news/ascrs-releases-preliminary-cypass-withdrawal-consensus-statement/2479843/The American Society of Cataract and Refractive Surgery convened a CyPass Withdrawal Task Force to review the data from the COMPASS-XT study and related research and develop an independent physician guidance document associated with the voluntary withdrawal of Alcon’s CyPass Micro-Stent. To